VAERS Explorer
Back to explore

Report #2850278

Received Jul 18, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
37 yrs
State
SC
Recovered
Unknown
Vaccinated
Feb 26, 2025
Onset
Jun 25, 2025
Days to onset
119
Hospital days
—

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.3Y014059—
HPV9HPV (GARDASIL 9)MERCK & CO. INC.1——
HPV9HPV (GARDASIL 9)MERCK & CO. INC.2——

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

no additional AE; Second dose on 3/31/2025, and Third dose administered today, 6/25/2025; This spontaneous report was received from a Pharmacist and refers to a 37-year-old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. The patient received 3 dose series of vaccination with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) Suspension for injection – dose 1 on 26-FEB-2025 (dose, lot#, expiration date, route and site of vaccination were not provided), dose 2 on 31-MAR-2025 (dose, lot#, expiration date, route and site of vaccination were not provided), and dose 3 on 25-JUN-2025 (inappropriate schedule of vaccine administered) (lot #Y014059, expiration date: 01-Nov-2026), 0.5 mL (route and site of administration were not provide). No additional adverse event was reported.